“It’s always interesting when there’s a new administration and a new political configuration”
Washington healthcare policy insider Terry Haines offers his thoughts on COVID relief, the future of the Affordable Care Act and more.
Regulatory
Numerous groups are attempting to diversify COVID vaccine research
With communities of color historically underrepresented in clinical trials, numerous groups are working to diversify COVID-19 vaccine research.
FDA cracks down on e-cigarette makers that didn’t submit marketing applications
The agency sent warning letters to vape companies selling e-cigarettes without premarket authorization.
COVID-19 kicks drug pricing down the road
The attention to the upcoming presidential election also dims the likelihood of legislation efforts until 2021.
Pharma industry, Trump publicly negotiate drug pricing rules
President Trump is putting pressure on the pharma industry ahead of the presidential election.
House committee to investigate how USPS slowdown affects prescriptions by mail
The House Energy and Commerce subcommittee on health began an investigation this week.
Telehealth executive order aims to extend temporary changes
President Trump’s executive order calls for regulation to make some of the changes permanent.
Pandemic or no, pharma needs to push drug pricing dialogue
Although the world is still months away from a COVID-19 vaccine, it’s imperative that pharma companies have the conversation right now about the cost of innoculation.
Vaccine makers and lawmakers stress importance of accessible COVID-19 vaccine
Leaders from pharma companies developing COVID-19 vaccines appeared before Congress on Tuesday.
Senate Democrats call to provide a COVID-19 vaccine for free
In a white paper, Senate Democrats urge the Trump administration to ensure a COVID-19 vaccine is free for Americans.
Want to read more?
Please login or register first to view this content.
